Affibodies as an alternative to antibodies in biosensors for cancer markers
M.D. Harris, Cranfield University, UK
S. Tombelli and G. Marazza, Università degli Studi di Firenze, Italy
A.P.F. Turner, Cranfield University, UK and Linköping University, Sweden
Abstract:
Development of immunoassays and immunosensors for detection and monitoring of cancer markers is currently a major area of research and, as more markers are discovered and their role in disease becomes better understood, this will continue to grow. Success of these assays is largely due to the properties of the antibodies used to capture and detect the analyte, resulting from the high sensitivity and specificity of immunoglobulins. However, they are not without ...
Get Biosensors for Medical Applications now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
